The Perfect Enemy | Author: Julio Marchi | Page 493
July 12, 2025

Julio Marchi

Technology Scientist, Executive, and Entrepreneur. Specialized in Internet Products Development, Digital Security, and IT Coaching. System Engineer by degree, Musician and Writer by passion. Journalist and Magazines Publisher in a previous life (getting back to it now). Currently hosting the "Julio Marchi Speaks Out Show" on YouTube.

A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

Study designThis was an investigator-initiated, single-blinded, 1:1 randomized vaccine clinical study, designed to assess the reactogenicity and immunogenicity of heterologous...